Aging Fuels Breast Cancer Spread Through Immune System Changes

Older mice showed significantly higher rates of breast cancer metastasis to the lungs, even with similar tumor growth, due to age-related immune system decline. Researchers at Georgetown’s Lombardi Comprehensive Cancer Center identified a weakened anti-tumor response in aging animals. This suggests that immune senescence may be a key factor in cancer progression with age.

Older mice exhibited significantly higher rates of breast cancer metastasis to the lungs compared to younger counterparts, despite similar primary tumor growth. This finding emerged from research conducted at Georgetown’s Lombardi Comprehensive Cancer Center, which pinpointed age-related immune system decline as a critical factor in cancer progression. The study highlights that while tumor size remained comparable across age groups, the spread of cancer to distant organs was markedly increased in older animals. Researchers identified a weakened anti-tumor immune response in aging mice, suggesting that immune senescence—natural deterioration of immune function with age—may be a key driver behind the heightened metastatic risk observed in older individuals. The exact mechanisms linking immune decline to cancer spread remain under investigation, but the results underscore the importance of the immune system in containing tumor progression.

The work builds on growing scientific interest in how aging influences cancer outcomes, particularly in diseases like breast cancer where age is a known risk factor. Prior studies have noted associations between aging and increased cancer incidence, but this research offers a more direct biological explanation by isolating immune function as a central variable. The Georgetown team’s focus on metastasis—rather than primary tumor growth—shifts attention toward the body’s ability to prevent cancer from spreading, a critical phase in disease seve